Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

16 June 2022: Clinical Research

Remimazolam Tosilate Sedation with Adjuvant Sufentanil in Chinese Patients with Liver Cirrhosis Undergoing Gastroscopy: A Randomized Controlled Study

YingHao Cao 1ADEF , Ping Chi 2AE , Chen Zhou 3CD , WenFei Lv 2B , ZheFen Quan 2BF , Fu Shan Xue 1ADEF*

DOI: 10.12659/MSM.936580

Med Sci Monit 2022; 28:e936580

Table 3 Primary and secondary outcomes.

Subjects, n7474
Primary outcome
Endoscopist satisfactionSatisfied68 (91.8%)57 (77.0%)0.543
Fair5 (6.8%)13 (17.6%)0.085
Unsatisfied1 (1.4%)4 (5.4%)0.367
Secondary outcomes
Respiratory depression2 (2.7%)13 (17.6%)0.007
ApneaNil3 (4.1%)0.245
Body movement6 (8.1%)17 (23.0%)0.043
BradycardiaNil4 (5.4%)0.1021
Hypotension3 (4.1%)11 (14.9%)0.031
Nausea or vomiting2 (2.7%)1 (1.4%)1.000
SomnolenceNil3 (4.1%)0.245
Dizziness1 (1.4%)3 (4.1%)0.621
Patient satisfactionSatisfied74 (100.0%)72 (97.3%)0.908
FairNil2 (2.7%)0.497

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750